Stay updated on RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe footer’s ClinicalTrials.gov revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check18 days agoChange DetectedA notice appears announcing NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and linking to related updates and FAQs.SummaryDifference0.6%

- Check25 days agoChange DetectedThe footer now identifies the site as running revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check32 days agoChange DetectedThe ClinicalTrials.gov site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check53 days agoChange DetectedA new revision tag v3.7.0 was added to the record history, replacing the previous v3.6.6 entry. This reflects an update to the page's history-tracking version.SummaryDifference0.1%

- Check74 days agoChange DetectedA new site revision entry (v3.6.6) was added to the history and the previous revision (v3.6.5) was removed, indicating a software release update to the page rather than changes to trial data or visible content.SummaryDifference0.1%

Stay in the know with updates to RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page.